Literature DB >> 25454610

Prostate cancer outcomes: the three questions.

Adam W Glaser1, Jessica L Corner2.   

Abstract

Enhanced survival and therapeutic choices for men with prostate cancer mandate the evaluation of the "quality of survival". An exciting series of local, national and international health outcome improvement initiatives offer the enticing prospect of assessing and improving this.
Copyright © 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Year:  2014        PMID： 25454610     DOI： 10.1016/j.eururo.2014.10.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  4 in total

Review 1.  The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer.

Authors:  Claire L Tonry; Emma Leacy; Cinzia Raso; Stephen P Finn; John Armstrong; Stephen R Pennington
Journal:  Diagnostics (Basel)       Date:  2016-07-18

2.  Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.

Authors:  Sarah Wilding; Amy Downing; Penny Wright; Peter Selby; Eila Watson; Richard Wagland; David W Donnelly; Luke Hounsome; Hugh Butcher; Malcolm Mason; Ann Henry; Anna Gavin; Adam W Glaser
Journal:  Qual Life Res       Date:  2019-05-21       Impact factor: 4.147

3.  Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

Authors:  James W F Catto; Amy Downing; Samantha Mason; Penny Wright; Kate Absolom; Sarah Bottomley; Luke Hounsome; Syed Hussain; Mohini Varughese; Caroline Raw; Phil Kelly; Adam W Glaser
Journal:  Eur Urol       Date:  2021-02-10       Impact factor: 20.096

4.  Urinary, bowel and sexual health in older men from Northern Ireland.

Authors:  David W Donnelly; Conan Donnelly; Therese Kearney; David Weller; Linda Sharp; Amy Downing; Sarah Wilding; Penny Wright; Paul Kind; James W F Catto; William R Cross; Malcolm D Mason; Eilis McCaughan; Richard Wagland; Eila Watson; Rebecca Mottram; Majorie Allen; Hugh Butcher; Luke Hounsome; Peter Selby; Dyfed Huws; David H Brewster; Emma McNair; Carol Rivas; Johana Nayoan; Mike Horton; Lauren Matheson; Adam W Glaser; Anna Gavin
Journal:  BJU Int       Date:  2018-03-25       Impact factor: 5.588
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.